TELA Bio (TELA) Retained Earnings (2018 - 2026)

TELA Bio's Retained Earnings history runs 9 years deep, the most recent figure standing at $404.5 million for Q1 2026.

• On a quarterly basis, Retained Earnings rose 209.33% year-over-year to $404.5 million in Q1 2026; TTM through Mar 2026 was $404.5 million, a 209.33% increase from a year earlier, with the FY2025 full-year figure at -$397.6 million, down 10.82% from the prior year.
• Retained Earnings improved to $404.5 million in Q1 2026 per TELA's latest filing, from -$397.6 million in the prior quarter.
• Across five years, Retained Earnings topped out at $404.5 million in Q1 2026 and bottomed at -$397.6 million in Q4 2025.
• The 5-year median for Retained Earnings is -$253.5 million (2022), against an average of -$103.2 million.
• Across the five-year window, Retained Earnings surged 232.91% in 2023 and slumped 394308.79% in 2024, its largest moves.
• Year by year, Retained Earnings stood at -$274.2 million in 2022, then jumped by 100.03% to $91000.0 in 2023, then slumped by 394308.79% to -$358.7 million in 2024, then slipped by 10.82% to -$397.6 million in 2025, then soared by 201.75% to $404.5 million in 2026.
• Per Business Quant, the three latest TELA Retained Earnings figures stand at $404.5 million (Q1 2026), -$397.6 million (Q4 2025), and -$388.5 million (Q3 2025).